Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Omeros Corp (OMER)  
$3.15 0.09 (2.94%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 61,650,000
Market Cap: 194.20(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.08 - $7.57
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 6.1
Insider 3/6 Months : 6.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Omeros is a commercial-stage biopharmaceutical company. Co. is focused on discovering, developing and commercializing small-molecule and protein therapeutics for larger-market as well as orphan indications targeting immunologic diseases. Co.'s drug candidate narsoplimab is the subject of a biologics license application pending before the U.S. Food and Drug Administration for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Co. has various late-stage clinical development programs in its pipeline, which are focused on: complement-mediated disorders, including immunoglobulin A nephropathy, atypical hemolytic uremic syndrome and COVID-19.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 25,000 25,000 25,000
Total Buy Value $0 $40,500 $40,500 $40,500
Total People Bought 0 2 2 2
Total Buy Transactions 0 2 2 2
Total Shares Sold 0 0 10,000 10,000
Total Sell Value $0 $0 $64,950 $64,950
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 125
  Page 3 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-07-26 4 OE $4.10 $191,900 D/D 43,000 192,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-07-26 4 AS $21.53 $753,687 D/D (35,000) 184,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-07-12 4 AS $21.48 $91,886 D/D (4,277) 184,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-07-12 4 OE $4.10 $17,536 D/D 4,277 188,922     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2018-05-15 4 OE $9.37 $166,898 D/D 17,812 13,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2018-05-15 4 AS $24.95 $319,659 D/D (12,812) 8,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2018-05-14 4 AS $22.45 $246,501 D/D (10,980) 8,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2018-05-14 4 OE $9.37 $102,883 D/D 10,980 19,480     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2018-01-04 4 OE $9.37 $9,370 D/D 1,000 8,500     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-01-03 4 OE $6.05 $634,312 D/D 70,532 184,645     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2018-01-03 4 AS $21.45 $1,341,226 D/D (62,528) 176,641     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2018-01-03 4 AS $22.45 $22,899 D/D (1,020) 7,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2018-01-03 4 OE $9.37 $9,557 D/D 1,020 8,520     -
   Demopulos Gregory A Md Chairman, CEO & President   •       •      –    2017-12-28 4 OE $2.45 $413,838 D/D 142,001 2,026,986     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2017-08-21 4 OE $6.05 $48,400 D/D 8,000 176,641     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2017-06-16 4 AS $24.95 $299,400 D/D (12,000) 7,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2017-06-16 4 OE $9.37 $131,180 D/D 14,000 19,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2017-06-15 4 AS $22.45 $269,400 D/D (12,000) 5,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2017-06-15 4 OE $9.37 $131,180 D/D 14,000 17,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2017-06-14 4 AS $19.95 $186,533 D/D (9,350) 3,500     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2017-06-14 4 OE $9.37 $120,404 D/D 12,850 12,850     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2017-06-13 4 AS $19.95 $52,868 D/D (2,650) 0     -
   Jacobsen Michael A VP Finance and CAO   •       –      –    2017-06-13 4 OE $9.37 $24,831 D/D 2,650 2,650     -
   Cable Thomas J. Director   –       •      –    2017-04-12 4 AS $16.49 $49,474 D/D (3,000) 40,067     -
   Kelbon Marcia S. VP Patent and General Counsel   •       –      –    2017-03-20 4 OE $6.05 $12,342 D/D 2,040 168,641     -
  125 Records found
  1  2  3  4  5   
  Page 3 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us